… public policy and advocacy, on March 19-21 in Washington, D.C. for the 2018 Parkinson's Policy Forum. The event … members of Congress on the needs and priorities of the PD community. Specifically, they will speak about the need for … been more drugs enter clinical testing than ever before. However, there is no cure to slow or stop disease …

… Foundation celebrates second regulatory approval from funded portfolio with FDA decision on … know from our research and discussions with the Parkinson’s community that ‘off’ time can significantly disrupt daily … Executive Officer Antony Loebel, MD, said, “We understand how profoundly disruptive these off periods are and are …

… Study Rationale:  Compared with the general population, people with Parkinson’s disease (PD) are more likely to fall and break a bone as a result of disease-related … people with PD. Next Steps for Development:  Understanding how the risk for fracture can be affected by differences in …

… Study Rationale: NOD2 is a key component of our immune defense system that detects invading … NOD2 activity has a ‘Goldilocks-like’ balance; not too active or too inactive, but just right. However, when NOD2 becomes dysregulated (either overactive … computer modeling …

… builds upon the research from a prior grant: Using LRRK2 Computer Simulations to Identify Therapeutic Targets for Parkinson's Disease … of biological pathways involved in Parkinson's disease and how genetic mutations in LRRK2 can change that system so …

… everything behind, Hien Nguyen made countless sacrifices to give his children opportunities he never had. His values … Determined to honor their father, Andrew and Athena committed themselves to a mission that would reflect his … Athena, “but watching Andrew’s determination and seeing how much it meant to my dad made me believe I could.”  …